BioSpace News Archive

Business

Centene, North Carolina Medical Society And North Carolina Community Health Center Association Awarded Medicaid Contract

Joint Venture to Offer Unique Approach to Medicaid Reform in North Carolina

February 4, 2019

·

10 min read

Policy

CHMP Recommends Approval of Praluent® (alirocumab) Injection to Reduce Cardiovascular Risk in People with Established Atherosclerotic Cardiovascular Disease

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the CHMP has adopted a positive opinion for Praluent® Injection

February 4, 2019

·

13 min read

Business

Macherey-Nagel GmbH & Co. KG and Andrew Alliance Sign Co-Marketing Agreement

Macherey-Nagel GmbH & Co. KG and Andrew Alliance announced they have signed an agreement stating that they are working together to develop an automated solution for the preparation of transfection grade plasmid DNA.

February 4, 2019

·

1 min read

Business

argenx and Halozyme Enter Global Collaboration and License Agreement for ENHANZE® Technology

argenx gains access to ENHANZE® subcutaneous delivery technology for up to three targets, including exclusive rights to develop therapeutic products targeting human neonatal Fc receptor FcRn

February 4, 2019

·

8 min read

Drug Development

GenSight Biologics reports topline results at Week 48 of the RESCUE Phase III clinical trial of GS010 in subjects within six months of visual loss onset due to Leber Hereditary Optic Neuropathy (LHON)

Mean best-corrected visual acuity (BCVA) among GS010-treated eyes and sham-treated eyes evolved with similar trajectories, worsening to a low point, or nadir, before beginning to improve by Week 48 – coherent with REVERSE trial

February 4, 2019

·

13 min read

Elekta: New Study to Learn From Every Cancer Patient Treated With Magnetic Resonance Radiation Therapy

The MOMENTUM study is a transformative approach to evaluating innovative medical technology

February 4, 2019

·

5 min read

Age Labs awarded €1 million in R&D funding from the Research Council of Norway

Age Labs is developing a precise novel biomarker that will measure biological aging, by utilising extensive and unique datasets from Norwegian biobanks combined with machine learning.

February 4, 2019

·

2 min read

Drug Development

BioArctic Announces That Eisai Will Initiate Phase 3 Confirmatory Study With BAN2401 in Early Alzheimer’s Disease

BioArctic AB announced that Eisai stated at their Q3 FY2018 Financial Results Meeting on February 4, 2019 that a single Phase 3 confirmatory study of BAN2401 in early Alzheimer´s disease patients is under preparation and planned to be initiated within Eisai’s FY2018 i.e. the first quarter 2019.

February 4, 2019

·

6 min read

Business

Statement - Let’s recognize and support the contributions of Canada’s medical residents

National Resident Awareness Week is an opportunity to recognize the contribution of over 12,000 medical residents who deliver care to Canadians across the country.

February 4, 2019

·

1 min read

Policy

Medical Students Meet with Members of Parliament on Steps to Improve Seniors Care and Aging for all Canadians

Over 70 medical students from across Canada are on Parliament Hill today to meet with Members of Parliament and policy advisors to discuss concrete actions to improve seniors care and healthy aging in Canada.

February 4, 2019

·

3 min read